Trial: 201805117

A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-based Treatment Combinations in Patients with Metastatic Colorectal Cancer (MORPHEUS-CRC)

Phase

I/II

Principal Investigator

Pedersen, Katrina

Disease Site

Colon; Rectum

Learn more about this study at: clinicaltrials.gov